నైరూప్య

Translational research of vitiligo and its pathogenesis and therapeutic implications.

Christina Berg*

Vitiligo, a typical depigmenting skin jumble, has an expected commonness of 0.5-2% of the populace around the world. The sickness is described by the specific loss of melanocytes which results in common nonscaly, powdery white macules. As of late, impressive headway has been made in how we might interpret the pathogenesis of vitiligo which is presently obviously delegated an immune system sickness. Vitiligo is many times excused as a corrective issue, in spite of the fact that its belongings can be mentally destroying, frequently with an impressive weight on day to day existence. In 2011, a global agreement arranged segmental vitiligo independently from any remaining types of vitiligo, and the term vitiligo was characterized to assign all types of nonsegmental vitiligo.